scholarly journals Does the origin of ablated premature ventricular contractions determine the level of left ventricle remodeling?

2020 ◽  
Author(s):  
Agnieszka Wojdyła-Hordyńska ◽  
Patrycja Pruszkowska-Skrzep ◽  
Philipp Sommer ◽  
Gerhard Hindricks ◽  
Piotr Feusette ◽  
...  
Keyword(s):  
Left Ventricle ◽  
Premature Ventricular Contractions ◽  
Left Ventricle Remodeling

PO328 Effect of Valsartan on Left Ventricle Remodeling in Patients With Dual Chamber Pacemaker

Global Heart ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. 450-451
Author(s):  
A. Tomasik ◽  
G. Banasik ◽  
D. Kawecki ◽  
C. Wojciechowska ◽  
W. Jacheć ◽  
...  
Keyword(s):  
Left Ventricle ◽  
Dual Chamber ◽  
Dual Chamber Pacemaker ◽  
Left Ventricle Remodeling

scholarly journals THE INFLUENCE OF EARLY LEFT VENTRICLE REMODELING OVER QTC CHANGES IN HIGHLY TRAINED PREADOLESCENT FOOTBALLERS

2014 ◽  
pp. 23-27
Author(s):  
Marija Zdravkovic ◽  
Branislav Milovanovic ◽  
Mirjana Krotin ◽  
Sinisa Dimnkovic ◽  
Dragan Lovic ◽  
...  
Keyword(s):  
Left Ventricle ◽  
Left Ventricle Remodeling

scholarly journals Sex differences in the evolution of left ventricle remodeling in rats with severe volume overload

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Elisabeth Walsh-Wilkinson ◽  
Marie-Claude Drolet ◽  
Marie Arsenault ◽  
Jacques Couet
Keyword(s):  
Sex Differences ◽  
Left Ventricle ◽  
Volume Overload ◽  
Left Ventricle Remodeling

scholarly journals The utility of atrial overdrive pacing during catheter ablation of premature ventricular contractions originating from the posterior-superior process of the left ventricle

2018 ◽  
Vol 18 (4) ◽  
pp. 128-131
Author(s):  
Nobutaka Masunaga ◽  
Yasuharu Matsunaga-Lee ◽  
Sen Matsumoto ◽  
Kouichi Tachibana ◽  
Yuzuru Takano
Keyword(s):  
Catheter Ablation ◽  
Left Ventricle ◽  
Premature Ventricular Contractions ◽  
Overdrive Pacing

scholarly journals Predictors of Left Ventricle Remodeling: Combined Plasma B-type Natriuretic Peptide Decreasing Ratio and Peak Creatine Kinase-MB

2017 ◽  
Vol 14 (1) ◽  
pp. 75-85 ◽  
Author(s):  
Jen-Te Hsu ◽  
Chang-Min Chung ◽  
Chi-Ming Chu ◽  
Yu-Shen Lin ◽  
Kuo-Li Pan ◽  
...  
Keyword(s):  
Creatine Kinase ◽  
Left Ventricle ◽  
Natriuretic Peptide ◽  
Left Ventricle Remodeling ◽  
Creatine Kinase Mb

P778Valsartan reduces level of soluble ST2 and left ventricle remodeling in patients with dual chamber pacemaker

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
E Radzik ◽  
K T Pigon ◽  
G B Banasik ◽  
A T Tomasik ◽  
W J Jachec ◽  
...  
Keyword(s):  
Heart Failure ◽  
Left Ventricle ◽  
Systolic Dysfunction ◽  
Protective Role ◽  
Alternative Mechanism ◽  
Dual Chamber ◽  
Double Blind ◽  
Dual Chamber Pacemaker ◽  
Soluble St2 ◽  
Left Ventricle Remodeling

Abstract Introduction Permanent right ventricle pacing leads to left ventricle remodeling, its systolic dysfunction and symptomatic heart failure in the long run. Valsartan is well known for its preventive anti-remodeling function in the post infarction heart remodeling. Objectives To assess the effect of valsartan on left ventricle remodeling in patients with second and third degree atrioventricular block with first-time implantation of dual chamber pacemaker. Methods This was a randomized, double-blind, placebo controlled single center study. One hundred eligible patients were assigned in a 1:1:1 fashion to receive placebo, valsartan 80mg or 160mg once daily, respectively. Echocardiographic assessment of left ventricle geometry, its systolic and diastolic function was performed at baseline and at twelve months. One patient from placebo group suffered stroke. We present the baseline date for 100 enrolled patients and follow-up data for 88 patients who have completed the study. Data in valsartan arms are pooled in one group. Concentration of soluble ST2 was measured in duplicates with Aspect Reader (Critical Diagnostics). Results Results are presented in table. Data are presented as mean and standard deviation. Table 1 Placebo (n=28) Valsartan (n=60) ANOVA Baseline 12 mths Baseline 12 mths sST2, ng/mL 36.0±16.0 39.4±15.3 35.1±15.2 19.9±6.5 0.01 LVEF, % 60±8 55±9 60±8 58±8 0.01 LVEDD, mm 48±5 50±4 48±6 49±5 NS LVESD, mm 29±4 32±5 29±5 31±4 NS LVEDV, mL 79±12 84±13 80±12 81±13 NS LVESV, mL 32±5 38±7 31±5 34±6 0.01 E/A 0.94±0.12 0.92±0.13 0.94±0.15 0.95±0.15 NS DecT, ms 211±38 226±43 223±45 218±37 0.01 IVRT, ms 98±14 108±17 101±17 99±18 0.01 Conclusion Valsartan has protective effect of left ventricle remodeling and function. It may be useful in prevention of pacing induced heart failure. Decrease in soluble ST2 concentration may help explain the alternative mechanism for protective role of valsartan. (NCT01805804)

Sign in / Sign up

Export Citation Format

Share Document